Fig 1.
PRISMA flow chart detailing the study selection process.
Table 1.
Socio-demographic characteristics of the participants from the eligible studies.
Fig 2.
Forest plot of the studies reporting the association between ART use and hypertension.
The solid line on the Forest plot is the point of no effect (OR = 1) and the dashed line represents the overall pooled estimate. The grey squares and horizontal lines represent the odds ratios of each study and their 95% confidence intervals. The size of the grey square represents the weight contributed by each study in the meta-analysis. The diamond represents the pooled odds ratio and its 95% confidence intervals.
Table 2.
Individual and pooled odds ratios of the studies reporting the association between ART use and hypertension.
Fig 3.
Forest plot of the studies reporting the association between ART use and diabetes mellitus.
The solid line on the Forest plot is the point of no effect (OR = 1) and the dashed line represents the overall pooled estimate. The grey squares and horizontal lines represent the odds ratios of each study and their 95% confidence intervals. The size of the grey square represents the weight contributed by each study in the meta-analysis. The diamond represents the pooled odds ratio and its 95% confidence intervals.
Table 3.
Pooled and individual odds ratios of the studies reporting the association between ART use and diabetes mellitus.
Fig 4.
Forest plot of the studies reporting the association between ART use and high total cholesterol.
The solid line on the Forest plot is the point of no effect (OR = 1) and the dashed line represents the overall pooled estimate. The grey squares and horizontal lines represent the odds ratios of each study and their 95% confidence intervals. The size of the grey square represents the weight contributed by each study in the meta-analysis. The diamond represents the pooled odds ratio and its 95% confidence intervals.
Table 4.
Pooled and individual odds ratios of the studies reporting the association between ART use and high total cholesterol.
Fig 5.
Forest plot of the studies reporting the association between ART use and high serum triglyceride.
The solid line on the Forest plot is the point of no effect (OR = 1) and the dashed line represents the overall pooled estimate. The grey squares and horizontal lines represent the odds ratios of each study and their 95% confidence intervals. The size of the grey square represents the weight contributed by each study in the meta-analysis. The diamond represents the pooled odds ratio and its 95% confidence intervals.
Table 5.
Pooled and individual odds ratios of the studies reporting the association between ART use and high serum triglyceride.
Fig 6.
Forest plot of the studies reporting the association between ART use and low HDL-cholesterol.
The solid line on the Forest plot is the point of no effect (OR = 1) and the dashed line represents the overall pooled estimate. The grey squares and horizontal lines represent the odds ratios of each study and their 95% confidence intervals. The size of the grey square represents the weight contributed by each study in the meta-analysis. The diamond represents the pooled odds ratio and its 95% confidence intervals.
Table 6.
Pooled and individual odds ratios of the studies reporting the association between ART use and low HDL-cholesterol.
Fig 7.
Forest plot of the studies reporting the association between ART use and high LDL-cholesterol.
The solid line on the Forest plot is the point of no effect (OR = 1) and the dashed line represents the overall pooled estimate. The grey squares and horizontal lines represent the odds ratios of each study and their 95% confidence intervals. The size of the grey square represents the weight contributed by each study in the meta-analysis. The diamond represents the pooled odds ratio and its 95% confidence intervals.
Table 7.
Pooled and individual odds ratios of the studies reporting the association between ART use and high LDL-cholesterol.